SEC Info - vTv Therapeutics Inc. - IPO: ‘S-1/A’ on 7/20/15

SEC Info℠

Home

Help

Please Sign In

vTv Therapeutics Inc. – IPO: ‘S-1/A’ on 7/20/15 – ‘COVER’

On: Monday, 7/20/15, at 6:05am ET · Private-to-Public: Document `¶` – Release Delayed to: 8/26/15 · Accession #: 1567619-15-955 · File #: 333-204951

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 7/20/15  vTv Therapeutics Inc.             S-1/A¶                 7:11M                                    Broadridge Fin’l… Inc/FA

Initial Public Offering (IPO): Pre-Effective Amendment to Registration Statement (General Form) — Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML   2.58M 
                (General Form)                                                   
 7: COVER     ¶ Comment-Response or Cover Letter to the SEC         HTML      6K 
 2: EX-10.13    Material Contract                                   HTML     86K 
 3: EX-10.14    Material Contract                                   HTML     86K 
 4: EX-10.15    Material Contract                                   HTML     86K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML      6K 
 6: EX-23.2     Consent of Experts or Counsel                       HTML      6K

Delayed-Release ‘COVER’ — Comment-Response or Cover Letter to the SEC

This is an HTML Document rendered as filed. [ Alternative Formats ]

Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas
New York, New York 10019-6064

July 20, 2015

Via EDGAR

Mr. Ronald E. Alper
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549

vTv Therapeutics Inc.
Amendment No. 3 to Registration Statement on Form S-1

Filed July 13, 2015
File No. 333-204951

Ladies and Gentlemen:

On behalf of our client, vTv Therapeutics Inc., a Delaware corporation (the “Company”), we hereby submit in electronic form the accompanying Amendment No. 4 (“Amendment No. 4”) to the Registration Statement on Form S-1 of the Company (the “Registration Statement”), marked to indicate changes from Amendment No. 3 to the Registration Statement filed with the Securities and Exchange Commission (the “Commission”) on July 13, 2015.

Amendment No. 4 reflects the inclusion of a preliminary price range for the Company’s Class A common stock, certain information previously left blank in the Registration Statement that is derived from such price range, pro forma financial information as well as certain additional changes.

* * * *

If you have any questions concerning the above, please do not hesitate to contact either the undersigned at (212) 373-3052 or David E. Sobel at (212) 373-3226.

Sincerely,

/s/ Lawrence G. Wee

Lawrence G. Wee, Esq.

cc:	Stephen L. Holcombe
	vTv Therapeutics Inc.

	Marc D. Jaffe, Esq.
	Senet S. Bischoff, Esq.
	Latham & Watkins LLP

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-1/A’ Filing	Date	Other Filings

Filed on:	7/20/15	FWP
	7/13/15	CORRESP, S-1/A
		List all Filings

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/29/22  vTv Therapeutics Inc.             10-K       12/31/21   97:11M                                    ActiveDisclosure/FA
 2/24/21  vTv Therapeutics Inc.             10-K       12/31/20  100:10M                                    ActiveDisclosure/FA
11/24/20  vTv Therapeutics Inc.             S-1                    3:514K                                   ActiveDisclosure/FA

↑Top

Filing Submission 0001567619-15-000955 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)